Publication: Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience.
No Thumbnail Available
Identifiers
Date
2021
Authors
Domínguez-Gil, Beatriz
Fernández-Ruiz, Mario
Hernández, Domingo
Crespo, Marta
Colmenero, Jordi
Coll, Elisabeth
Rubio, Juan José
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Spain has been amongst the countries most affected by the COVID-19 pandemic, which has posed significant challenges to the donation and transplantation program. Despite a dramatic decrease of donation and transplantation activities during the critical early weeks of the outbreak, the program has recovered and is learning to cope with COVID-19. We describe the 4 pillars upon which the Spanish donation and transplantation program has been rebuilt. (1) Standards have been developed and progressively updated for the evaluation and selection of potential donors and recipients with regards to SARS-CoV-2 infection. (2) Spain has been actively generating evidence to assess the validity of our standards and to understand the natural history of the infection in transplant recipients. No case of donor-derived COVID-19 has been reported to date. COVID-19 has been more frequent and has had a more aggressive course in recipients of solid organ transplants than in the general population, but this seems largely explained by the demographics and comorbidity of transplant patients. (3) As a result of this evidence and experience, recommendations have been issued for the management of COVID-19 in solid organ transplant recipients and candidates on the waiting list. (4) Finally, concrete guidance has been issued for centers to manage the donation and transplantation programs in relation to a dynamic and heterogeneous epidemiologic scenario. The Spanish experience confronting the impact of COVID-19 upon donation and transplantation may help serve the needs of a broader community in other countries.
Description
MeSH Terms
COVID-19
Humans
Immune Tolerance
Organ Transplantation
SARS-CoV-2
Spain
Tissue and Organ Procurement
COVID-19 Drug Treatment
Humans
Immune Tolerance
Organ Transplantation
SARS-CoV-2
Spain
Tissue and Organ Procurement
COVID-19 Drug Treatment